A detailed history of Franklin Resources Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, Franklin Resources Inc holds 19,122,675 shares of AZN stock, worth $1.25 Billion. This represents 0.45% of its overall portfolio holdings.

Number of Shares
19,122,675
Previous 19,280,736 0.82%
Holding current value
$1.25 Billion
Previous $1.5 Billion 0.82%
% of portfolio
0.45%
Previous 0.43%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 27, 2024

SELL
$76.67 - $87.62 $12.1 Million - $13.8 Million
-158,061 Reduced 0.82%
19,122,675 $1.49 Billion
Q3 2024

Nov 12, 2024

BUY
$76.67 - $87.62 $129 Million - $147 Million
1,680,776 Added 9.55%
19,280,736 $1.5 Billion
Q2 2024

Aug 14, 2024

BUY
$66.81 - $80.83 $25.2 Million - $30.5 Million
377,844 Added 2.19%
17,599,960 $1.37 Billion
Q1 2024

May 13, 2024

BUY
$61.03 - $69.57 $453 Million - $516 Million
7,416,616 Added 75.64%
17,222,116 $1.17 Billion
Q4 2023

Feb 09, 2024

SELL
$61.89 - $69.28 $93.5 Million - $105 Million
-1,511,019 Reduced 13.35%
9,805,500 $660 Million
Q3 2023

Nov 13, 2023

BUY
$64.85 - $71.7 $147,144 - $162,687
2,269 Added 0.02%
11,316,519 $766 Million
Q2 2023

Aug 11, 2023

SELL
$69.91 - $75.81 $39.7 Million - $43 Million
-567,395 Reduced 4.78%
11,314,250 $810 Million
Q1 2023

May 12, 2023

SELL
$63.15 - $71.6 $72.8 Million - $82.5 Million
-1,152,404 Reduced 8.84%
11,881,645 $825 Million
Q4 2022

Feb 10, 2023

SELL
$54.21 - $70.44 $203 Million - $263 Million
-3,735,738 Reduced 22.28%
13,034,049 $884 Million
Q3 2022

Nov 14, 2022

SELL
$53.02 - $135.75 $17.3 Million - $44.3 Million
-326,360 Reduced 1.91%
16,769,787 $920 Million
Q2 2022

Aug 11, 2022

BUY
$59.26 - $71.14 $102 Million - $122 Million
1,718,792 Added 11.18%
17,096,147 $1.13 Billion
Q1 2022

May 13, 2022

BUY
$55.72 - $67.12 $294 Million - $354 Million
5,280,347 Added 52.3%
15,377,355 $1.02 Billion
Q4 2021

Feb 11, 2022

BUY
$54.02 - $63.83 $30.9 Million - $36.5 Million
572,432 Added 6.01%
10,097,008 $588 Million
Q3 2021

Nov 12, 2021

BUY
$55.56 - $60.79 $198 Million - $216 Million
3,556,457 Added 59.59%
9,524,576 $572 Million
Q2 2021

Aug 13, 2021

SELL
$48.42 - $60.18 $10.4 Million - $12.9 Million
-213,780 Reduced 3.46%
5,968,119 $357 Million
Q1 2021

May 13, 2021

SELL
$47.16 - $54.44 $10 Million - $11.6 Million
-213,092 Reduced 3.33%
6,181,899 $307 Million
Q4 2020

Feb 10, 2021

BUY
$48.52 - $58.02 $13.1 Million - $15.6 Million
269,290 Added 4.4%
6,394,991 $320 Million
Q3 2020

Nov 12, 2020

SELL
$53.07 - $61.1 $11.1 Million - $12.8 Million
-209,529 Reduced 3.31%
6,125,701 $336 Million
Q2 2020

Aug 13, 2020

BUY
$43.1 - $55.31 $22.8 Million - $29.3 Million
529,731 Added 9.12%
6,335,230 $361 Million
Q1 2020

May 13, 2020

BUY
$37.79 - $51.33 $14.6 Million - $19.9 Million
387,659 Added 7.16%
5,805,499 $259 Million
Q4 2019

Feb 12, 2020

BUY
$42.46 - $50.46 $1.29 Million - $1.53 Million
30,382 Added 0.56%
5,417,840 $270 Million
Q3 2019

Nov 14, 2019

BUY
$40.12 - $45.47 $27.5 Million - $31.2 Million
685,908 Added 14.59%
5,387,458 $240 Million
Q2 2019

Aug 14, 2019

BUY
$37.28 - $41.68 $2.96 Million - $3.31 Million
79,394 Added 1.72%
4,701,550 $194 Million
Q1 2019

May 14, 2019

BUY
$35.49 - $43.02 $2.7 Million - $3.27 Million
75,986 Added 1.67%
4,622,156 $187 Million
Q4 2018

Feb 12, 2019

BUY
$36.86 - $41.49 $36.4 Million - $41 Million
988,663 Added 27.79%
4,546,170 $173 Million
Q3 2018

Nov 13, 2018

BUY
$34.76 - $39.72 $70 Million - $80 Million
2,015,215 Added 130.66%
3,557,507 $141 Million
Q2 2018

Aug 14, 2018

BUY
$34.55 - $37.05 $19.1 Million - $20.5 Million
552,089 Added 55.76%
1,542,292 $54.2 Million
Q1 2018

May 10, 2018

SELL
$32.97 - $36.63 $18,595 - $20,659
-564 Reduced 0.06%
990,203 $34.6 Million
Q3 2017

Nov 13, 2017

BUY
$28.96 - $34.0 $28.7 Million - $33.7 Million
990,767
990,767 $33.6 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $203B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Franklin Resources Inc Portfolio

Follow Franklin Resources Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.